Day One Biopharmaceuticals, Inc. (DAWN)
9.62
-0.01
(-0.10%)
USD |
NASDAQ |
Dec 24, 12:41
Day One Biopharmaceuticals SG&A Expense (TTM): 116.18M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Mersana Therapeutics, Inc. | 31.53M |
| Iovance Biotherapeutics, Inc. | 158.68M |
| Lantheus Holdings, Inc. | 439.11M |
| iRhythm Technologies, Inc. | 470.32M |
| Perspective Therapeutics, Inc. | 31.53M |